Switch View
© PR Newswire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR
News Preview
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ: LRMR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ: LRMR) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call
News Preview
ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 6, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
16.10.2025
ISIN: US98985Y1082
Zymeworks Inc
ZYME
LISTED
NYSE
Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
News Preview
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
16.10.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Sectra adds Smith+Nephew 3D templates to its orthopaedic solution--supporting wider adoption of digital surgical planning
News Preview
LINKÖPING, Sweden, Oct. 16, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies, Smith+Nephew. Extending the r...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: FR0013154002
Sartorius Stedim Biotech SA
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): 9 Month figures
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025 16-Oct-2025 / 07:00 CET/CEST
Aubagne, France | October 16, 2025
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Sales revenue reaches 2,195 mi......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius schärft Prognose nach deutlich profitablem Umsatzwachstum in den ersten neun Monaten
News Preview
Göttingen, 16. Oktober 2025
Sartorius schärft Prognose nach deutlich profitablem Umsatzwachstum in den ersten neun Monaten
Konzernumsatz steigt in den ersten neun Monaten um 7,5 Prozent
Signifikanter Zuwachs im Wiederholgeschäft mit Verbrauchsmaterialien hält weiter an
Sparte Bioprocess Solutions wächst um rund 10 Prozent; Laborsparte erholt......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months
News Preview
Göttingen, Germany | October 16, 2025
Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months
Group sales revenue up 7.5 percent in the first nine months
Significant growth in recurring business with consumables continues
Bioprocess Solutions Division grows by around 10 percent, lab division rec......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
CAMBRIDGE, MA, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
News Preview
Press Release // October 16, 2025
Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, “Formycon”) announces that Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global c......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien und Lateinamerika
News Preview
Pressemitteilung // 16. Oktober 2025
Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien und Lateinamerika
Planegg-Martinsried – Die Formycon AG (FWB: FYB, “Formycon”) gibt bekannt, dass die Klinge Biopharma GmbH (“Klinge”), Lizenznehmer und exklusiver Inhaber der welt......
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KYG0146B1032
Akeso Inc
9926
LISTED
HKSE
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation
News Preview
HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF bispecific antibody...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
News Preview
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases
Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic i...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
News Preview
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases
Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic i...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025
News Preview
Basel, 16 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented major updates on its innovative sequencing by expansion (SBX) technology at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in Boston, USA. Following its recent unveiling, SBX is already being recognized by early evaluators in the sequencing community for its co...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CH0325814116
Kuros Biosciences AG
KURN
LISTED
SIX
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
News Preview
Ad hoc announcement pursuant to Article 53 of the SIX listing rules...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Stockholder Alert: Robbins LLP Informs MoonLake Immunotherapeutics Stockholders that a Class Action Lawsuit was Filed Against the Company
News Preview
SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025. MoonLake is a Swiss clinical-stage biotechno...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or fai...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASD...
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2025
ISIN: CA00654D1006
Adastra Holdings Ltd.
XTRX
LISTED
CSE
Adastra Holdings Announces Completion of Sale of Subsidiaries
News Preview
Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("11...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purch...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ATYR PHARMA INC. (ATYR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECO...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter of 2025 after the close of market on Tuesday, November 4, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m....
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US2288951088
Cryo-Cell International, Inc.
CCEL
LISTED
XASE
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
News Preview
Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2025.
Financial Results
Revenue
Consolidated revenues for the third quarter of fiscal 2025 were $7.83...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that new data from across its oncology portfolio will be presented in 15 accepted abstracts at the European Society for Medical Oncology (ESMO) Congress 2025, taking place October 17–21 in Berlin, Germany. These presentations span the cancer care treatment co...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
News Preview
Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need
Leverages Existing Infrastructure and Expertise in Central Nervous System Therapy Area...
Themefolio
Profiler
Peergroup
© Newsfile
15.10.2025
ISIN: CA78471G1000
SOL Global Investments Corp.
SOL
LISTED
CSE
SOL Global Announces Change of Auditor
News Preview
Toronto, Ontario--(Newsfile Corp. - October 15, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") today announce that it has changed its auditor from Zeifmans LLP ("Former Auditor") to HDCPA Professional Corporation ("Successor Auditor"), effective immediately.The change of auditor was approve...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Announces CFO Transition Plan
News Preview
Provides Preliminary Revenue for Fourth Quarter and Full Year Fiscal 2025
FRANKLIN LAKES, N.J., Oct. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, an...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call an...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US89377M1099
Transmedics Group Inc
TMDX
LISTED
NASDAQ
TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025
News Preview
ANDOVER, Mass., Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025
News Preview
Conference Call Scheduled for Wednesday, October 22 at 4:30 p.m. Eastern Time
SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focuse...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3837800006
Hoya Corp
77410
LISTED
XJPX
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
News Preview
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy
MONTVALE, N.J., Oct. 16, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3837800006
Hoya Corp
77410
LISTED
XJPX
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
News Preview
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy
MONTVALE, N.J., Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical System...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3837800006
Hoya Corp
77410
LISTED
XJPX
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
News Preview
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy
MONTVALE, N.J., Oct. 15, 2025 /CNW/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Systems, Inc....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3837800006
Hoya Corp
77410
LISTED
XJPX
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
News Preview
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy
MONTVALE, N.J., Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical System...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3837800006
Hoya Corp
77410
LISTED
XJPX
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
News Preview
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy
MONTVALE, N.J., Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical System...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter 2025 financial results on Wednesday, November 5, 2025, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on November 5, 2025, at 4:30 p.m. Eastern Time.
The conference call will be availa...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: CA45783P5085
Innocan Pharma Corporation
INNO
LISTED
CSE
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
News Preview
Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan's World Third Largest Pharmaceutical Market
HERZLIYA, Israel and CALGARY, AB, Oct. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innoca...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: CA45783P5085
Innocan Pharma Corporation
INNO
LISTED
CSE
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
News Preview
Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan's World Third Largest Pharmaceutical Market
HERZLIYA, Israel and CALGARY, AB, Oct. 15, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or t...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of MLTX d...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commiss...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Lantheus Holdings, Inc.
News Preview
RADNOR, Pa., Oct. 15, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus secu...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
News Preview
Cytek® Biosciences expands European presence with new facility in Amsterdam to better serve customers and drive growth...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (NASDAQ: LFMD) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
News Preview
PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Cl...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health to Announce Third Quarter 2025 Financial Results
News Preview
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. ...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
News Preview
A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in the Eastern District of New York, comes after a dramatic stock price decline in Augus...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman
News Preview
Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex co...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
News Preview
SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX® Medical, Inc., to acquire the C2 CryoBalloon™ device and related technology. The closi...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US7458481014
Pulmonx Corp
LUNG
LISTED
NASDAQ
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
News Preview
REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2025 after the close of trading on Wednesday, October 29, 2025. Thereafter, comp...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US00650F1093
Adaptive Biotechnologies Corp
ADPT
LISTED
NASDAQ
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the third quarter 2025 after market cl...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US68752L1008
OrthoPediatrics Corp
KIDS
LISTED
NASDAQ
OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025
News Preview
WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2025 financial results on October 28, 2025 after the market closes. Ort...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
